Initial public offerings (IPOs) have started to pick up steam across the medtech industry over the past couple of years.

In 2025, the medtech industry saw another year full of all kinds of deals in the mergers and acquisitions (M&A) arena.

The new CEO will replace Stanley Bergman, who announced his retirement in July after 45 years with Henry Schein.

Fresenius Medical Care, a major provider of renal disease products, will start the new year with a new global chief medical ...

Here are the largest medtech funding rounds — all of which equaled or exceeded $150 million — of 2025: Waltham, Massachusetts ...

Makatsaria and LivaNova’s leadership outlined the company’s plan for growth during a November Investor Day event. He spoke to ...

Philips (NYSE: PHG) operates in a wide range of spaces as one of the largest companies in the world, including Connected Care ...

Significant changes at Johnson & Johnson were among the most-read medtech news on MassDevice over the past year.

Edwards Lifesciences announced today that its Sapien M3 mitral valve replacement system received FDA approval for mitral ...

Picard Medical (NYSE:PMI) announced today that it entered into a definitive agreement for a private placement financing of up ...

Solventum (NYSE:SOLV) announced today that it completed its previously announced acquisition of Acera Surgical.

After leaving Medtronic this month, former EVP of Enterprise Operations Greg Smith is now chief supply chain officer at ...